2024 EXPERT SPEAKER FACULTY

2024 Speakers - 7th Annual TPD & Induced Proximity Summit

WORLD-CLASS ACADEMICS
BIOPHARMA LEADERS

World Leading Academics

Alessio Ciulli

Founder, Director & Professor - Chemical & Structural Biology

University of Dundee

Andrew Tsourkas

Professor

University of Pennsylvania

Christian Ottmann

Associate Professor

Eindhoven University of Technology

Christina Woo

Assistant Professor

Harvard University

Daniel Finley

Professor

Harvard Medical School

Dmitri Ivanov

Associate Professor

UT Health San Antonio

Elena De Vita

Assistant Professor

Queen Mary University of London

Eric fischer

Director

Harvard Medical School

Gary Kleiger

Chair & Professor

University of Las Vegas Nevada

Gisele Nishiguchi headshot

Gisele Nishiguchi

Group Leader

St. Jude Children's Research Hospital

Jian Jin

Mount Sinai Endowed Professor

Icahn School of Medicine at Mount Sinai

Kylie Walters

Senior Investigator

National Institutes of Health

Radoslav Enchev

Group Leader

The Francis Crick Institute

Raegan O’Lone

Senior Program Advisor

HESI

Stephanie Leuenroth-Quinn

Associate Director for Pharmacology and Toxicology

FDA

Stuart Schreiber

Professor - Morris Loeb. Chemistry & Chemical Biology, Emeritus Howard Hughes Medical Institute Investigator

Arena Bioworks

Zoran Rankovic

Director, Centre for Protein Degradation

The Institute for Cancer Research

Global Pharma & Biotech Leaders

Abhishek Dogra

Director - Medicinal Chemistry & Induced Proximity

A-Alpha Bio Inc.

Adrian Gottschalk

Chief Executive Officer

Foghorn Therapeutics

Amine Sadok

Director, Induced Proximity Platform

Amgen

Andreas Reichel

Vice President, Head Of DMPK Modelling & Simulations

Bayer

Andrew Hirsch

President & Chief Executive Officer

C4 Therapeutics

Anita Bellail

CSO

HB Therapeutics

Ankit Sharma

Associate Director, Medicinal Chemistry, Oncology Targeted Discovery

AstraZeneca

Arnout Schepers

Founder & Chief Executive Officer

TenAces Biosciences

Arthur T. Sands

Chief Executive Officer

Nurix Therapeutics

Arvind Shakya

Director

BioTheryx

Atul Tiwari Vice President - Discovery Strategy Sai Life Sciences, TPD & Induced Proximity Summit

Atul Tiwari

Vice President - Discovery Strategy

Sai Life Sciences

Barbara Lueckel

Global Head of Research Technologies

F. Hoffmann-La Roche

Benedict Cross

Chief Technology Officer & Head of Platform

Phoremost

Bernd Boidol

Chief Executive Officer

Proxygen

Bradlee Heckmann

Co-founder & Chief Scientific Officer

Asha Therapeutics

Carolyn Porter

CEO

Outrun Therapeutics

Charu chaudhry

Associate Director

Johnson & Johnson Services, Inc

Chinatsu Sakata-Sakur

Vice President

Astellas Pharma

Christian Dillon

Chief Scientific Officer

PhoreMost

Diogo Feleciano

Co-Founder & Chief Scientific Officer

Booster Therapeutics

Effie Tozzo

Chief Scientific Officer

Avilar Therapeutics

Elizabeth Caine

scientist

Promega

Ethan Toriki Novartis TPD

Ethan Toriki

Discovery Postdoctoral Fellow

Novartis AG

Eugene L. Chekler

Director

Bristol Myers Squibb

Gang Yao

Associate Director

GSK

Giovanni Spagnolli

Co-Founder & Chief Technology Officer

Sibylla Biotech

Greg Michaud

Director

Novartis AG

Hailong Zhang

Chief Executive Officer

Blueray Biopharma

Harris Bell-Temin

Director - Proteomics

Johnson & Johnson Innovative Medicine

Henrik Daub

Founder & Chief Scientific Officer

NEOsphere Biotechnologies

Jaehyun Choi

Co-founder & Chief Executive Officer

Genexine, Inc.

Jason Kantor

Chief Business Officer

Nurix Therapeutics

Jessica Sims

Principal Scientist Toxicology

Genentech

JF Brazeau

Director

Plexium

Joachim Rudolph

Senior Fellow Discovery Chemistry

Genentech

Johan Johansson

Associate Principal Scientist, CVRM PROTAC Lead, Project Leader

AstraZeneca

John Guilinger X Chem TPD

John Guilinger

Senior Director, Lead Discovery & Biochemistry

X-Chem Pharmaceuticals

John Houston

Chairman, Chief Executive Officer & President

Arvinas

Juliet Williams

Head of Research

Kymera Therapeutics

Kanak Raina

Exec Director

Halda Therapeutics

Karteek Kadimisetty

Director

LifeSensors

Katie Spooner, TPD Summit

Katie Spooner

Research Analyst

Hanson Wade

Kelly Rainbolt

Senior Scientist

Lyterian Therapeutics

Ken Yamada

Associate Director

Novartis

Keunsoo Kang

Chief Scientific Officer

Deargen

Len Reyno

Chief Medical Officer

C4 Therapeutics

Leo Fu

Co-Founder & Chief Technology Officer

GluBio Therapeutics

Lise Loberg

Preclinical Safety Expert

AbbVie

Mark Niosi

Principal Scientist

Pfizer

Matthias Brand

Co-Founder & Chief Scientific Officer

Proxygen

Maureen Spit headshot

Maureen Galmes-Spit

VP Research

Laigo Bio

Michael Chen, TPD Summit

Michael Chen

Chief Executive Officer

Nuclera

Nan Ji

Co- Founder, President & Chief Executive Officer

PAQ Therapeutics

Natalie nairn

CEO

Cyclera Therapeutics

Neil Bence

Vice President, Oncology Discovery

Bristol Myers Squibb

Neil Torbett, TPD & Induced Proximity Summit

Neil Torbett

CEO

PhoreMost

Nello Mainolfi

Founder, President & Chief Executive Officer

Kymera Therapeutics

Nina Ilic, TPD Summit

Nina Ilic-Widlund

Associate Director - Oncology

Monte Rosa Therapeutics

Pat Sharp

Co-Founder

Gate Bioscience

Paula O’Connor

Chief Medical Officer

Nurix Therapeutics

Peggy Scherle

Chief Scientific Officer

Prelude Therapeutics

Raegan O’Lone

Senior Program Advisor

HESI

Randolph Lopez

Co-Founder & Chief Technology Officer

A-Alpha Bio

Randy Teel

Chief Business Officer

Arvinas

Riccardo Sabatini

Chief Data Scientist

Orionis Biosciences

Rick Ewing

Vice President & Head of Chemistry

Rapafusyn

Ryan Kerrigan

Principal Scientist II

Novartis

Sarah Carratt

Principal Scientist

Pfizer

Scott Boyle

Chief Business Officer

C4 Therapeutics

Sean Zhu, TPD Summit

Sean Zhu

Senior Director

Kymera

Shyra Gardai

Chief Scientific Officer

EpiBiologics

Steven Bellon

Chief Scientific Officer

Foghorn Therapeutics

Stewart Fisher

Chief Scientific Officer

C4 Therapeutics

Vivek K Vishnudas, Ph.D, TPD Summit

Vivek Vishnudas

Vice President - Drug Discovery Non Clinical Development, Chief Technology Officer, Site Head of Research & Development

BPGBio Inc.

William Housley

Principal Research Scientist

Abbvie

Wu Du

Senior Vice President Medicinal Chemistry

Hinova Pharmaceuticals

Xiaoran han

vp

Cullgen

Ya-Wen Lu

Associate Director

Nurix Therapeutics

Yao Wang

Chief Medical Officer

Kangpu Biopharmaceuticals

Yong Cang

Co-Founder & Chief Scientific Officer

Degron Therapeutics

Zhifeng Yu

Director of Assay & DEL Screening

WuXi Apptec

2024 EVENT GUIDE
REGISTER INTEREST
PARTNER FOR 2025